UroGen Pharma is a biotech company that builds novel solutions to revolutionize the way specialty cancers and urologic diseases are treated – because patients deserve better options. Our vision is grounded in our RTGel® drug delivery technology, our promising pipeline, and a collaborative drive for bold results. Our existing technology: the RTGel drug delivery technology has the potential to be applied to a variety of unmet medical needs. RTGel reverse-thermal hydrogel is liquid at lower temperatures and converts to gel form at body temperature, offering the opportunity to make local therapy a more effective treatment. Our promising pipeline: Ranging from pre-clinical to Phase 3, we currently have multiple candidates in our pipeline, which are furthering the study of potential treatment advances in urology, uro-oncology, and immunology. Our collaborative drive: We are part of a broad ecosystem of partners who are seeking to improve patient care; these connections are vital to our commitment to offer new pathways and advance solutions. We are continually evaluating new partnership opportunities.
View Top Employees from UroGen PharmaWebsite | http://urogen.com/ |
Employees | 219 (209 on RocketReach) |
Founded | 2004 |
Address | 400 Alexander Park Drive 4th Floor, Princeton, New Jersey 08540, US |
Industry | Biotechnology |
Looking for a particular UroGen Pharma employee's phone or email?
Caretha Creasy is the Vice President, Early Development of UroGen Pharma.
209 people are employed at UroGen Pharma.
UroGen Pharma is based in Princeton, New Jersey.